Business context and reporting period
ASGN Incorporated (NYSE: ASGN) filed this unaudited Form 10-Q for the three months ended March 31, 2019. The filing describes its Apex and Oxford staffing businesses and ECS government and commercial IT services business. The request metadata names Everforth Inc, but the filing identifies ASGN Incorporated as the registrant; verify the intended issuer.
Financial performance
- Revenue: $923.7 million, up 34.8% from $685.2 million. The increase includes $168.0 million from ECS, acquired in April 2018. On the company’s pro forma basis, revenue increased 10.7% to $923.7 million from $834.3 million.
- Profit and margins: Gross profit was $263.9 million, up 21.2% reported; reported gross margin declined to 28.6% from 31.8%. Operating income was $62.7 million versus $45.7 million. Net income was $34.9 million versus $29.1 million; diluted EPS was $0.66 versus $0.55. Pro forma gross margin was 28.6%, down from 29.3%.
- Operating costs and interest: SG&A was $187.4 million, or 20.3% of revenue, versus $164.4 million, or 24.0%. Intangible amortization rose to $13.8 million from $7.6 million. Interest expense increased to $14.5 million from $6.6 million, primarily reflecting acquisition-related borrowings.
- Cash flow and liquidity: Operating cash flow was $44.0 million versus $54.7 million; cash flow before working-capital changes was $70.6 million. Investing used $57.0 million, including $48.8 million for DHA. Cash declined by $6.2 million to $35.6 million. Working capital was $377.7 million, and revolving-credit availability was $190.1 million.
- Debt and leases: Long-term debt carrying value was $1,107.7 million; gross borrowings were $1,130.0 million. The weighted-average borrowing rate was 4.5%. The company was covenant-compliant, with secured debt to EBITDA of 2.65:1. Adoption of lease accounting brought $91.4 million of operating lease right-of-use assets and $96.9 million of lease liabilities onto the March 31 balance sheet.
Material changes and segment results
- Apex: Revenue rose 12.5% to $606.1 million; gross margin declined to 28.9% from 29.5%. Management cited higher billable hours and a 5.8% increase in average bill rates, alongside mix pressure from large, lower-margin accounts.
- Oxford: Revenue increased 2.0% to $149.6 million and gross margin declined to 39.4% from 40.3%. Management said growth adjusted for billable days and foreign exchange would have been 3.5 percentage points higher.
- ECS: Revenue was $168.0 million. Pro forma revenue grew 12.7%; excluding DHA, ECS growth was 6.0%. Gross margin was 17.6%, compared with 17.9% pro forma in the prior-year quarter.
- Acquisition: ASGN acquired DHA Group on January 25, 2019, for $48.8 million. DHA contributed $10.0 million of quarterly revenue and $24.8 million of goodwill; acquisition purchase accounting remained incomplete.
- Backlog: ECS contract backlog was $1,776.5 million at March 31, versus $1,446.6 million at December 31, 2018. This included $244.0 million associated with DHA. The ECS book-to-bill ratio was 1.5:1.
Outlook, risks, and unusual items
The filing provides no quantified revenue or earnings guidance. Management said expected operating cash flows and revolving-credit availability should be sufficient for obligations, working capital, and capital expenditures over the next 12 months. It cited demand, talent availability and retention, competition, growth management, systems performance, acquisition integration, litigation, and ECS backlog as factors that could affect results. Government funding cycles and changes to contract awards or options may affect backlog; unfunded backlog is not assured revenue.
Variable-rate debt creates interest-rate exposure: the company estimated that a 100-basis-point rate change would alter annual interest expense by approximately $11.3 million. Management did not believe a 10% foreign-currency move would materially affect the financial statements. The quarter included $1.4 million of acquisition, integration, and strategic-planning expenses and a $1.4 million expense related to resolving a prior-period pay-rate dispute. The company reported no material change in commitments, no material expected effect from pending ordinary-course legal matters, and no material change in market-risk disclosures.
Most important facts to verify
- Confirm the issuer: the supplied metadata says Everforth Inc, while the filing is for ASGN Incorporated.
- Review the DHA purchase-price allocation, which was still preliminary, and the acquisition’s subsequent contribution and integration costs.
- Assess ECS backlog composition, including the substantial negotiated unfunded portion, and subsequent contract funding, awards, or protests.
- Check debt balances, covenant headroom, refinancing and variable-rate exposure, particularly in light of acquisition-related leverage.
- Reconcile reported growth with pro forma comparisons and track ongoing gross-margin pressure from business and contract mix.
- Evaluate operating cash conversion and working-capital movements, including receivables and cash held outside the United States.